+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID05688904

Testing Topical Imipramine to Reduce Pain and Improve Photodynamic Therapy for Precancerous Skin Lesions

Led by Wright State University · Updated on 2026-08-20

24

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of topical Imipramine combined with topical photodynamic therapy PDT to treat patients who have multiple precancerous skin lesions called actinic keratosis AKs. PDT is a common dermatological treatment for these skin precancers. While both imipramine and PDT are FDA-approved individually, this study is investigating the new approach of using imipramine before PDT to see if it reduces pain and improves effectiveness. Participants will be randomly assigned to receive either topical 4% imipramine or a placebo vehicle before undergoing PDT treatment on areas such as the face, scalp, or forearms. This study uses a double-blind design so neither participants nor researchers know which treatment is given. The treatments are applied topically, and the study focuses on how the combination impacts pain and treatment success. Throughout the study, participants will be monitored for pain and itch levels immediately after PDT and up to 30 minutes post-treatment, as well as at 6 months follow-up. Researchers will also measure the number of precancerous lesions remaining six months after PDT. Participants need to avoid excess sun exposure to the treated areas during the study. The total study duration extends up to six months after PDT treatment.

CONDITIONS

Brief Title

The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy

Research Team

M

Manager, Clinical Research Operations

R

Regulatory Specialist

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here